Advertisement DEA suspends Cardinal Health's substance control license - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

DEA suspends Cardinal Health’s substance control license

The US Drug Enforcement Administration is temporarily suspending Cardinal Health's license to distribute controlled substances from its Auburn, Washington distribution center.

The company said the suspension affects only the Washington facility and only controlled substance shipments from that facility. Steps are being taken to ensure continuity of service to its customers.

The Drug Enforcement Administration (DEA) said that Cardinal Health “failed to maintain effective controls against the diversion of a particular controlled substance,” and cites the sale of hydrocodone, a painkiller, to one pharmacy that allegedly dispensed excessive amounts of the drug based on illegitimate prescriptions from internet pharmacy web sites.